Evidence map›Paper›PMID 33330639›Full record

ArticleFrontiers in cardiovascular medicine2020

Aspirin Bioactivity for Prevention of Cardiovascular Injury in COVID-19.

Temistocles Diaz, Barry H Trachtenberg, Samuel J K Abraham, Rao KosagiSharaf, Armando A Durant-Archibold

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Aspirin and P2Y12 inhibitors in treating COVID-19.European journal of internal medicine · 2023
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Temistocles DiazInternal Medicine-Interventional Cardiology, Department of Cardiology, Punta Pacifica Hospital, Affiliate of John Hopkins Medicine International, Panama City, Panama.
Barry H TrachtenbergDepartment of Cardiology, Houston Methodist DeBakey Heart and Vascular Center, Houston, TX, United States.
Samuel J K AbrahamDepartment of Surgery & Centre for Advancing Clinical Research (CACR), Yamanashi University, Chuo, Japan.
Rao KosagiSharafBiomedicine Research Unit, Center for Biodiversity and Drug Discovery, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT Asociation of Public Interest), Panama City, Panama.
Armando A Durant-ArchiboldBiomedicine Research Unit, Center for Biodiversity and Drug Discovery, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT Asociation of Public Interest), Panama City, Panama.
Instituto de Investigaciones Científicas y Servicios de Alta Tecnología · PAEdogawa Hospital · JPHospital Punta Pacifica · PAHouston Methodist · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

aspirinCOVID-19molecular mechanismsprevention of cardiovascular diseaseSARS-CoV-2

Identifiers

PMID33330639
PMCPMC7734129
OpenAlexW3106697558

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.